• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

SonoSite launches 180 system

Article

Hand-held ultrasound manufacturer SonoSite has begun shipping its SonoSite 180 ultrasound system worldwide. SonoSite received the CE Mark Sept. 15 for the system. The certification gives the Bothell, WA, company rights to distribute the system throughout

Hand-held ultrasound manufacturer SonoSite has begun shipping its SonoSite 180 ultrasound system worldwide. SonoSite received the CE Mark Sept. 15 for the system. The certification gives the Bothell, WA, company rights to distribute the system throughout the European Union.

The 5-lb unit allows for color power Doppler capability and uses digital broadband beam-forming technology. SonoSite received 510(k) clearance from the Food and Drug Administration for SonoSite 180 in April (SCAN 4/28/99) for such indications as gynecology, obstetrics, and abdominal imaging. The system is configured to offer both transabdominal and intravaginal imaging, according to SonoSite.

In other SonoSite news, the company has joined Office of the Future, a research and development consortium that is working to create a clinical office model that integrates technology, information, and design. The group plans to use SonoSite 180 in the exam and procedure rooms it is developing. Office of the Future includes such companies as Midmark, American Express Healthcare Finance, American Medical Development, GE Marquette Medical Systems, Health Care Data Systems, Hewlett-Packard, Lunar, and Sony Electronics Medical Systems.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.